Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06269081 · ClinicalTrials.gov registry record · NA

Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV

A NA study of HIV, sponsored by Medical College of Wisconsin.

Recruiting
Registry status
NA
Development phase
352
Enrollment target
1
Study location

NCT06269081: Recruiting NA study of HIV, sponsored by Medical College of Wisconsin.

NCT06269081 is a NA study of HIV that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 352 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06269081, a NA study of HIV, is actively recruiting participants, sponsored by Medical College of Wisconsin.

RECRUITING
Registry status
NA
Development phase
352 participants
Enrollment target
1
Study location

Study Summary

Engagement in HIV medical care and adherence to HIV medications are both essential in improving health outcomes among people living with HIV (PLH), but PLH living in rural areas-who suffer higher mortality rates than their urban counterparts-can confront multiple barriers to care engagement and adherence, especially as they face the logistical, medical, and social challenges associated with aging. This project will test the efficacy of two interventions to determine their impact on HIV health outcomes and quality of life among rural, older PLH living in the Southern U.S. The two interventions, adapted from evidence-based interventions and delivered remotely, are: (1) supportive-expressive peer social support groups and (2) strengths-based case management. We hypothesize that both interventions will increase viral suppression, antiretroviral therapy adherence, and health-related quality of life and decrease depressive symptoms. Results from this study will provide us with tools to improve health outcomes for rural older people living with HIV.

Primary Outcome

HIV viral load will be assessed using self-collected dried blood spot (DBS) samples, with samples collecting using HemaSpot devices. Viral suppression will be defined as a measured viral load less than or equal to 839 copies/mL.

Conditions Studied

Interventions

  • BEHAVIORAL Supportive-Expressive Peer Social Support Group Intervention
  • BEHAVIORAL Individual Strengths-Based Case Management Intervention

Study Locations (1)

Wisconsin

  • Center for AIDS Intervention Research, Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 352 participants
Start Date 2024-04-10
Est. Completion 2027-01-31
Phase NA
Medical College of Wisconsin

447 total trials

What NCT06269081 shows while recruiting

NCT06269081 is an interventional study that assigns participants to a tested intervention. The registered 352 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (20% lower).

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Supportive-Expressive Peer Social Support Group Intervention is the first listed.

NCT06269081 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06269081 about?

NCT06269081 is a clinical study titled "Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV". Engagement in HIV medical care and adherence to HIV medications are both essential in improving health outcomes among people living with HIV (PLH), but PLH living in rural areas-who suffer higher mortality rates than their urban counterparts-can confront multiple barriers to care engagement and adhe...

What is the current status of trial NCT06269081?

This trial is currently recruiting. It is a NA study. The enrollment target is 352 participants. The study started on 2024-04-10. Estimated completion is 2027-01-31.

What conditions does trial NCT06269081 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT06269081?

The interventions under investigation include: Supportive-Expressive Peer Social Support Group Intervention (BEHAVIORAL), Individual Strengths-Based Case Management Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06269081?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06269081 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06269081's enrollment target sits among peer trials

352 59th of 303 higher than 244 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05811936 · 352 participants · NA

    The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads

  • NCT06258941 · 352 participants · Phase 1

    Classroom Break, Cognition, and Fitness in Elementary School Children

  • NCT06337292 · 352 participants · Phase 3

    Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures

  • NCT07011732 · 352 participants · Phase 3

    A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06269081, the US trial registry maintained by the National Library of Medicine. NCT06269081 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.